Browse > Article
http://dx.doi.org/10.4014/jmb.2103.03057

Cardamonin Inhibited IL-1β Induced Injury by Inhibition of NLRP3 Inflammasome via Activating Nrf2/NQO-1 Signaling Pathway in Chondrocyte  

Jiang, Jianqing (No. 4 Trauma Area, Hangzhou Fuyang District Bone Injury Hospital of Traditional Chinese Medicine)
Cai, Mingsong (No. 4 Trauma Area, Hangzhou Fuyang District Bone Injury Hospital of Traditional Chinese Medicine)
Publication Information
Journal of Microbiology and Biotechnology / v.31, no.6, 2021 , pp. 794-802 More about this Journal
Abstract
In this study we investigated the role and mechanism of cardamonin on IL-1β induced injury in OA. CHON-001 cells were treated with cardamonin and IL-1β and transfected with silencing nuclear factor erythroid 2-related factor 2 (siNrf2). Cell viability was detected by Cell Counting Kit-8 assay and flow cytometer assay was utilized for cell apoptosis assessment. IL-6, IL-8, TNF-α and Nrf2 mRNA expression was tested by qRT-PCR. Western blot was employed to evaluate MMP-3, MMP-13, Collagen II, Nrf2, NQO-1, NLRP3, Caspase 1 and apoptosis-associated speck-like protein containing a caspase-1 recruitment domain (ASC) protein levels. In CHON-001 cells, IL-1β suppressed cell viability and Collagen II level while promoting cell apoptosis and expression of pro-inflammatory cytokines (IL-6, IL-8, TNF-α), MMPs (MMP-3, MMP-13), NQO-1, and NLRP3 inflammasome (NLRP3, Caspase 1 and ASC), with no significant influence on Nrf2. Cardamonin reversed the effect of IL-1β on cell viability, cell apoptosis, pro-inflammatory cytokines, MMPs, Collagen II, and NLRP3 inflammasome levels. In addition, cardamonin advanced Nrf2 and NQO-1 expression of CHON-001 cells. SiNrf2 reversed the function of cardamonin on IL-1β-induced cell apoptosis and expression of pro-inflammatory cytokines, Nrf2, NQO-1, and NLRP3 inflammasome in chondrocytes. Taken together Cardamonin inhibited IL-1β induced injury by inhibition of NLRP3 inflammasome via activating Nrf2/NQO1 signaling pathway in chondrocyte.
Keywords
Osteoarthritis; cardamonin; NLRP3 inflammasome; IL-$1{\beta}$; Nrf2/NQO-1;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kraus VB, Blanco FJ, Englund M, Karsdal MA, Lohmander LS. 2015. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthritis Cartilage 23: 1233-1241.   DOI
2 Chabane N, Zayed N, Afif H, Mfuna-Endam L, Benderdour M, Boileau C, et al. 2008. Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Osteoarthritis Cartilage 16: 1267-1274.   DOI
3 Goldring SR, Goldring MB. 2004. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin. Orthop. Relat. Res. (427Seppl): S27-36.
4 He Y, Moqbel SAA, Xu L, Ran J, Ma C, Xu K, et al. 2019. Costunolide inhibits matrix metalloproteinases expression and osteoarthritis via the NF-κB and Wnt/β-catenin signaling pathways. Mol. Med. Rep. 20: 312-322.
5 Sykiotis GP, Bohmann D. 2008. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev. Cell 14: 76-85.   DOI
6 Hintsala HR, Jokinen E, Haapasaari KM, Moza M, Ristimaki A, Soini Y, et al. 2016. Nrf2/Keap1 pathway and expression of oxidative stress lesions 8-hydroxy-2'-deoxyguanosine and nitrotyrosine in melanoma. Anticancer Res. 36: 1497-1506.
7 Liu X, Zhang X, Ding Y, Zhou W, Tao L, Lu P, et al. 2017. Nuclear factor E2-related factor-2 negatively regulates NLRP3 inflammasome activity by inhibiting reactive oxygen species-induced NLRP3 priming. Antioxid Redox Signal. 26: 28-43.   DOI
8 Zuo S, Zou W, Wu RM, Yang J, Fan JN, Zhao XK, et al. 2019. Icariin Alleviates IL-1β-Induced Matrix Degradation By Activating The Nrf2/ARE Pathway In Human Chondrocytes. Drug Des. Devel. Ther. 13: 3949-3961.   DOI
9 Sovani S, Grogan SP. 2013. Osteoarthritis: detection, pathophysiology, and current/future treatment strategies. Orthop. Nurs. 32: 25-36; quiz 37-38.   DOI
10 Blagojevic M, Jinks C, Jeffery A, Jordan KP. 2010. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 18: 24-33.   DOI
11 Loeser RF. 2006. Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. Arthritis Rheum. 54: 1357-1360.   DOI
12 Jacques C, Gosset M, Berenbaum F, Gabay C. 2006. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. Vitam. Horm. 74: 371-403.   DOI
13 Vina ER, Kwoh CK. 2018. Epidemiology of osteoarthritis: literature update. Curr. Opin. Rheumatol. 30: 160-167.   DOI
14 Zu Y, Mu Y, Li Q, Zhang ST, Yan HJ. 2019. Icariin alleviates osteoarthritis by inhibiting NLRP3-mediated pyroptosis. J. Orthop. Surg. Res. 14: 307.   DOI
15 Guermazi A, Roemer FW, Burstein D, Hayashi D. 2011. Why radiography should no longer be considered a surrogate outcome measure for longitudinal assessment of cartilage in knee osteoarthritis. Arthritis Res. Ther. 13: 247.   DOI
16 Tormalehto S, Mononen ME, Aarnio E, Arokoski JPA, Korhonen RK, Martikainen J. 2018. Health-related quality of life in relation to symptomatic and radiographic definitions of knee osteoarthritis: data from Osteoarthritis Initiative (OAI) 4-year follow-up study. Health Qual. Life Outcomes 16: 154.   DOI
17 Li YY, Huang SS, Lee MM, Deng JS, Huang GJ. 2015. Anti-inflammatory activities of cardamonin from Alpinia katsumadai through heme oxygenase-1 induction and inhibition of NF-κB and MAPK signaling pathway in the carrageenan-induced paw edema. Int. Immunopharmacol. 25: 332-339.   DOI
18 Hatziieremia S, Gray AI, Ferro VA, Paul A, Plevin R. 2006. The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages. Br. J. Pharmacol. 149: 188-198.   DOI
19 Zhang Y, Tikkinen KAO, Agoritsas T, Ayeni OR, Alexander P, Imam M, et al. 2014. Patients' values and preferences of the expected efficacy of hip arthroscopy for osteoarthritis: a protocol for a multinational structured interview-based study combined with a randomised survey on the optimal amount of information to elicit preferences. BMJ Open 4: e005536.   DOI
20 Dong HC, Li PN, Chen CJ, Xu X, Zhang H, Liu G, et al. 2019. Sinomenine attenuates cartilage degeneration by regulating miR-223-3p/NLRP3 inflammasome signaling. Inflammation 42: 1265-1275.   DOI
21 Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.) 25: 402-408.   DOI
22 Bijlsma JW, Berenbaum F, Lafeber FP. 2011. Osteoarthritis: an update with relevance for clinical practice. Lancet (London, England). 377: 2115-2126.   DOI
23 Shakibaei M, John T, Seifarth C, Mobasheri A. 2007. Resveratrol inhibits IL-1 beta-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann. NY Acad. Sci. 1095: 554-563.   DOI
24 Malek Mahdavi A, Mahdavi R, Kolahi S. 2016. Effects of l-carnitine supplementation on serum inflammatory factors and matrix metalloproteinase enzymes in females with knee osteoarthritis: A randomized, double-blind, placebo-controlled pilot study. J. Am. Coll. Nutr. 35: 597-603.   DOI
25 Haseeb A, Haqqi TM. 2013. Immunopathogenesis of osteoarthritis. Clin. Immunol. (Orlando, Fla.) 146: 185-196.   DOI
26 Xiang Q, Kang L, Wang J, Liao Z, Song Y, Zhao K, et al. 2020. CircRNA-CIDN mitigated compression loading-induced damage in human nucleus pulposus cells via miR-34a-5p/SIRT1 axis. EBioMedicine 53: 102679.   DOI
27 Xie F, Kovic B, Jin X, He X, Wang M, Silvestre C. 2016. Economic and humanistic burden of osteoarthritis: A systematic review of large sample studies. Pharmacoeconomics 34: 1087-1100.   DOI
28 Leong DJ, Sun HB. 2011. Events in articular chondrocytes with aging. Curr. Osteoporo. Rep. 9: 196-201.   DOI
29 2018. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 392: 1789-1858.   DOI
30 Goldring MB, Goldring SR. 2007. Osteoarthritis. J. Cell. Physiol. 213: 626-634.   DOI
31 Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, et al. 2015. Osteoarthritis. Lancet (London, England) 386: 376-387.   DOI
32 Tu C, Ma Y, Song M, Yan J, Xiao Y, Wu H. 2019. Liquiritigenin inhibits IL-1β induced inflammation and cartilage matrix degradation in rat chondrocytes. Eur. J. Pharmacol. 858: 172445.   DOI
33 Lee SE, Shin HT, Hwang HJ, Kim JH. 2003. Antioxidant activity of extracts from Alpinia katsumadai seed. Phytother. Res. 17: 1041-1047.   DOI
34 Wang Z, Xu G, Gao Y, Zhan X, Qin N, Fu S, et al. 2019. Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome. Acta Pharm. Sin. B. 9: 734-744.   DOI
35 Baroja-Mazo A, Martin-Sanchez F, Gomez AI, Martinez CM, Amores-Iniesta J, Compan V, et al. 2014. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat. Immunol. 15: 738-748.   DOI
36 Kaneko S, Satoh T, Chiba J, Ju C, Inoue K, Kagawa J. 2000. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell. Mol. Ther. 6: 71-79.   DOI
37 Goncalves LM, Valente IM, Rodrigues JA. 2014. An overview on cardamonin. J. Med. Food 17: 633-640.   DOI
38 Chow YL, Lee KH, Vidyadaran S, Lajis NH, Akhtar MN, Israf DA, et al. 2012. Cardamonin from Alpinia rafflesiana inhibits inflammatory responses in IFN-γ/LPS-stimulated BV2 microglia via NF-κB signalling pathway. Int. Immunopharmacol. 12: 657-665.   DOI
39 Ren G, Sun A, Deng C, Zhang J, Wu X, Wei X, et al. 2015. The anti-inflammatory effect and potential mechanism of cardamonin in DSS-induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 309: G517-527.   DOI
40 Wang K, Lv Q, Miao YM, Qiao SM, Dai Y, Wei ZF. 2018. Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway. Biochem. Pharmacol. 155: 494-509.   DOI
41 Tu C, Huang X, Xiao Y, Song M, Ma Y, Yan J, et al. 2019. Schisandrin a inhibits the IL-1β induced inflammation and cartilage degradation via suppression of MAPK and NF-κB signal pathways in rat chondrocytes. Front. Pharmacol. 10: 41.   DOI
42 Yu T, Qu J, Wang Y, Jin H. 2018. Ligustrazine protects chondrocyte against IL-1β induced injury by regulation of SOX9/NF-κB signaling pathway. J. Cell. Biochem. 119: 7419-7430.   DOI